Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BMO Capital Downgrades Crombie REIT to Market Perform

BMO Capital analyst Jenny Ma downgrades Crombie REIT (OTC:CROMF) from Outperform to Market Perform.

byBenzinga Newsdesk

July 26, 2021

1 minute read

BMO Capital analyst Jenny Ma downgrades Crombie REIT (OTC:CROMF) from Outperform to Market Perform.

News

Intel’s Mobileye Highlights Introduction Of EyeQ Ultra System-On-Chip Prupose-Built For Autonomous Driving

By Benzinga Newsdesk

Today, 10:50 AM

Mobileye introduces EyeQ® Ultra™ – a single package AV-on-chip super-computer that is purpose-built for end-to-end autonomous driving. Proven Mobileye EyeQ® architecture underpins EyeQ Ultra,

INTC

Why RBC Bearings Shares Are Gaining Today

By Akanksha Bakshi

Today, 10:50 AM

RBC Bearings Inc (NASDAQ:ROLL) reported fourth-quarter FY22 sales growth of 123.9% year-over-year to $358.9 million, beating the consensus of $349.79…

ROLL

Wells Fargo Maintains Equal-Weight on Thermo Fisher Scientific, Lowers Price Target to $605

By Benzinga Newsdesk

Today, 10:50 AM

Wells Fargo analyst Dan Leonard maintains Thermo Fisher Scientific (NYSE:TMO) with a Equal-Weight and lowers the price target from $700 to $605.

TMO

Recursion Pharmaceuticals Q3 EPS $(0.28) Up From $(1.09) YoY, Sales $2.53M Up From $1.02M YoY

By Benzinga Newsdesk

Today, 10:50 AM

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.28) per share. This is a 74.31 percent increase over losses of $(1.09) per share from the same period last year. The company reported $2.53

RXRX

BMO Capital Downgrades Crombie REIT to Market Perform

Related Posts

Intel’s Mobileye Highlights Introduction Of EyeQ Ultra System-On-Chip Prupose-Built For Autonomous Driving

Why RBC Bearings Shares Are Gaining Today

Wells Fargo Maintains Equal-Weight on Thermo Fisher Scientific, Lowers Price Target to $605

Recursion Pharmaceuticals Q3 EPS $(0.28) Up From $(1.09) YoY, Sales $2.53M Up From $1.02M YoY